Veltek Associates, Inc. will be attending the PDA/1600-LC-S-1644-03-100×100.jpg1600-LC-S-1644-02-100×100.jpg1600-LC-S-1644-01-100×100.jpg1600-LC-S-1643-03-100×100.jpg1600-LC-S-1643-02-100×100.jpgFDA Joint Regulatory Conference in Washington, DC from September 12th to the 14th, 2016. Our table top number is 35, so come by and say hello!

The PDA/1600-LC-S-1644-03-100×100.jpg1600-LC-S-1644-02-100×100.jpg1600-LC-S-1644-01-100×100.jpg1600-LC-S-1643-03-100×100.jpg1600-LC-S-1643-02-100×100.jpgFDA Joint Regulatory Conference, sponsored by the PDA and FDA, aims to enhance the understanding of the implications, expectations, and requirements of new regulatory initiatives and to add clarity to convey current thinking by the FDA. The Parenteral Drug Association has described this conference as one that has “consistently and successfully translated the ever-expanding and evolving public and private sector framework into a lexicon of terms and modern strategies aimed at advancing the FDA and medical products industries’ collective understanding. It has advanced efforts toward regulatory harmonization, regulatory science policy and current Good Manufacturing Practices, as well as elucidated contributing factors leading to drug shortage and accentuated the effects of industry globalization. Over the years, interactive discussion of these topics has helped to ensure that consistently safe and effective drugs are available to consumers throughout the entire commercial drug lifecycle.”